CBOE Stock Trades at 24% Discount to 52-Week High: More Upside Left?

Cboe Global Markets closed at $281.04, 24.2% below its $371.18 52-week high, while gaining 11.9% year to date versus a 9.4% decline for its industry. Management raised its 2026 organic net revenue growth outlook to low-double-digits through the mid-teens, supported by trading volumes and recurring Data Vantage revenue, though consensus forecasts a 29.2% earnings decline in 2026 despite 15.9% revenue growth. CBOE trades at 19.6x forward earnings versus a 21.4x industry average and retains $536.8 million of buyback authorization alongside 16 consecutive annual dividend increases; Zacks maintains a Hold rating amid mixed estimate revisions.

Analysis

The relevant debate is not whether CBOE is optically below a prior price peak, but whether its mix can sustain a premium earnings multiple while transaction revenues normalize. The unusually large gap between projected revenue growth and earnings growth points to a cost, mix, or accounting-item bridge that must be reconciled before underwriting a rerating. If incremental Data Vantage and index revenue is genuinely displacing lower-quality volume-linked revenue, CBOE can narrow its valuation discount to NDAQ; if not, the market will treat the growth outlook as volatility-dependent and cap the multiple closer to ICE.

The portfolio actions create a two-sided effect over the next 1-3 quarters: divestitures may improve reported expense growth and simplify the story, but also remove earnings and introduce stranded-cost or transition risk. The more durable competitive issue is index-options liquidity: CBOE's franchise benefits disproportionately when retail and institutional hedging demand rises, while NDAQ's data and workflow exposure is less tied to realized volatility. A compression in VIX and retail options activity would therefore hurt CBOE's transaction-led upside more than consensus likely assumes.

Contrarian view: the apparent discount may be deserved rather than a mean-reversion opportunity. Minimal forward estimate revisions despite a higher company outlook suggest analysts either question conversion to EPS or already expect offsetting expenses, dilution, and divestiture effects. The next earnings release is the key 1-3 month catalyst: recurring-revenue growth, operating-expense guidance, and the revenue-to-EPS bridge matter more than headline volume statistics.

Over 6-18 months, successful monetization of proprietary data, indices, and clearing/technology infrastructure would reduce cyclicality and support a NDAQ-like valuation framework. Falsification is clear: two consecutive quarters of Data Vantage growth below management's low-double-digit target, transaction revenue growth decelerating despite elevated options volumes, or post-divestiture expense guidance failing to decline would invalidate the quality-of-growth thesis.

Key Decisions for Investors

• Maintain a neutral CBOE exposure until the next earnings release; upgrade to long only if recurring-revenue growth clears the low-double-digit threshold and management provides a credible EPS bridge. A 10-15% rerating is plausible if CBOE closes even part of its relative multiple gap to NDAQ; downside is 10%+ if expense leverage does not emerge.
• For a market-neutral expression, consider long CBOE / short NDAQ over a 3-6 month horizon only after confirmation that Data Vantage growth is accelerating. This isolates a potential CBOE quality-of-revenue rerating from broad exchange-sector beta; exit if CBOE's recurring-revenue growth trails NDAQ's data/analytics growth for two quarters.
• Avoid using the buyback authorization as a standalone catalyst. Monitor actual quarterly repurchase pace versus free-cash-flow conversion and divestiture proceeds; a slowdown would signal capital is needed for integration, technology investment, or balance-sheet protection.
• Set an event alert around implied/realized volatility and index-options market-share data. A sustained volatility decline combined with share loss is a reason to short CBOE versus ICE, whose earnings mix is comparatively less exposed to retail-driven listed-options activity.